Edap Tms (FOCL) Depreciation & Amortization (CF) (2025 - 2026)
Edap Tms (FOCL) posted Depreciation & Amortization (CF) of $896000.0 for Q1 2026, up 18.99% on a QoQ basis from $753000.0 in Q1 2025, and up 18.99% year-over-year from $753000.0 in Q1 2025.
Edap Tms (FOCL) Depreciation & Amortization (CF) (2025 - 2026) Analysis & Trends
Edap Tms' Depreciation & Amortization (CF) history runs 2 years deep, the most recent figure standing at $896000.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 18.99% year-over-year to $896000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $896000.0 (up 18.99% YoY) and the FY2025 annual result came in at $3.4 million, up 22.69% from the prior year.
- Depreciation & Amortization (CF) was $896000.0 for Q1 2026 at Edap Tms, up from $753000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $896000.0 in Q1 2026 and bottomed at $753000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 67.00 Mn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 142.30 Mn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | 248.00 Mn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 81.00 Mn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | - |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 61.74 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | 896,000.00 |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 346,520.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 896,000.00 |
| Mar 31, 2026 | 896,000.00 |
| Mar 31, 2025 | 753,000.00 |
| Mar 31, 2025 | 753,000.00 |